FDA.reportPublic FDA data

Duobrii 0.01 % / 0.045 % Topical Lotion

RxCUI
2166094
RxNorm name
Duobrii 0.01 % / 0.045 % Topical Lotion
Display name
Duobrii 0.01 % / 0.045 % Topical Lotion
Full name
Duobrii 0.01 % / 0.045 % Topical Lotion
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DuobriiHALOBETASOL PROPIONATE AND TAZAROTENEBausch Health US, LLCb3f0cdc0-69fd-43d1-baf2-d776a3a207152020-01-01Warnings, Adverse reactionsExact identifier
rxcui: 2166094

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b3f0cdc0-69fd-43d1-baf2-d776a3a20715Duobrii 0.01 % / 0.045 % Topical Lotion [PSN] · halobetasol propionate 0.1 MG/ML / tazarotene 0.45 MG/ML Topical Lotion [Duobrii] [SBD] · Duobrii 0.01 % / 0.045 % Topical Lotion [SY]36These highlights do not include all the information needed to use DUOBRII safely and effectively. See full prescribing information for DUOBRII. DUOBRII ® (halobetasol propionate and tazarotene) lotion, for topical use Initial U.S. Approval: 201920200101